Reducing non-nutritive sweeteners during pregnancy and lactation
Official title: Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes (the SweetPea Trial)
Run by George Washington University · NCT06548828 · Data updated 2026-11-12
This study is testing if cutting back on non-nutritive sweeteners during pregnancy and breastfeeding can improve health for both mothers and their babies.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 324 (estimated) |
| Sponsor | George Washington University Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Status | Recruiting |
| Started | August 19, 2024 |
| Main results expected | February 29, 2028 |
| Study ends | February 1, 2029 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT06548828 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women aged 18-45, less than 16 weeks gestation, who frequently consume NNS and intend to breastfeed.
✕Probably not a fit
Patients with pre-existing gastrointestinal disorders, significant substance use, or those on medications affecting metabolism may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of reducing non-nutritive sweeteners (NNS) on maternal and infant health outcomes during pregnancy and lactation. Pregnant women who frequently consume NNS will be randomly assigned to either an NNS-restriction intervention or a control group with no restrictions. The study aims to assess how NNS consumption affects infant body composition, maternal blood sugar levels, and the infants' gut microbiome and metabolome. The findings could inform guidelines on NNS consumption for improving metabolic health in mothers and infants.
Why it matters
Potential benefit: If successful, this study could lead to improved health recommendations for pregnant women, potentially reducing the risk of obesity and metabolic diseases in infants.
How similar studies have gone: While the effects of NNS on pregnancy outcomes are not well understood, this approach is novel and has not been extensively tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant * ≤ 16 weeks gestation * Singleton pregnancy * Report frequent NNS beverage consumption (≥ 7 servings/week) * 18-45 years of age * Able to read English at a 5th grade level; and * Intend to breastfeed for at least the first 6 months of life. * For infants: The mother must be enrolled and provide assent for the infant to participate. Exclusion Criteria: * Physical or mental concerns preventing study participation; * Medication (e.g., metformin; GLP-1 agonists) use that may affect body weight, body composition, insulin resistance, or lipid profiles; * Tobacco or drug use during pregnancy; * Alcohol consumption (\>1 drink per week) during pregnancy; * Pre-existing gastrointestinal, inflammatory, or malabsorptive disorders (e.g., - Crohn's disease, ulcerative colitis, inflammatory bowel disease) that may impact NNS absorption or gut microbiota; * Known suspected/confirmed genetic fetal abnormalities or suspected or known congenital birth defects. * History of prior gastric bypass surgery.
Where it's running
-
The George Washington University
Washington D.C., District of Columbia, United States Recruiting
Study contacts
- Study coordinator: Allison C Sylvetsky, PhD
- Email: asylvets@gwu.edu
- Phone: 202-994-5602
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study
This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Behavioral toolkit to help pregnant women manage gestational diabetes and pregnancy-related high blood pressure.
This program will test whether a structured behavioral toolkit helps pregnant women with both gestational diabetes and pregnancy-induced high blood pressure better control their blood sugar and blood pressure.
-
Using a 24-hour continuous glucose monitor after delivery to predict future Type 2 diabetes risk in people with gestational diabetes
This pilot tests whether wearing a continuous glucose monitor for 24 hours immediately after delivery can help predict later Type 2 diabetes risk in people who had gestational diabetes.
-
Continuous glucose monitoring to find and manage early high blood sugar in pregnancy
This uses continuous glucose monitors in early pregnancy for people without diabetes to find and treat high blood sugar and try to reduce problems for mother and baby.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.